Business Context and Reporting Period
This Form 6-K filing by GSK plc is dated June 2, 2025, covering the month of June 2025. The report serves as a notification to the market regarding the Company's total voting rights and capital structure in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure details as of May 31, 2025:
- Issued Share Capital: 4,315,267,274 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 217,152,078 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,098,115,196.
Material Changes
The filing text does not provide comparative data against prior periods to identify material changes in share capital or voting rights.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It is a statutory notification intended to provide shareholders with the denominator required to calculate notification thresholds under FCA rules.
Investor Verification Checklist
- Verify the total number of voting rights (4,098,115,196) against internal holdings to determine if disclosure thresholds under FCA rules have been met.
- Confirm the number of shares held in Treasury (217,152,078) to ensure accurate calculation of outstanding voting shares.
- Note that this filing does not contain operational or financial performance updates; refer to Form 20-F or quarterly reports for such data.